Alpha fetoprotein (AFP) is used to screen for and monitor therapy for certain cancers of the liver and testes. In the presence of certain cancers, including bowel cancer, Carcino Embryonic Antigen (CEA) may be used to monitor the effect of treatment and recurrence of disease. CA 199 is a test to help tell the difference between cancer of the pancreas and bile ducts and other conditions; and to monitor response to pancreatic cancer treatment and to watch for recurrence. CA 125 is a test to monitor the treatment for ovarian cancer or to investigate for a possible ovarian cancer. BRCA1 & BRCA2 blood test assess the risk of developing breast and/or ovarian cancer. Having a faulty BRCA gene greatly increases a woman’s chance of developing breast cancer and ovarian cancer. This was the reason Angelina Jolie had preventative breast cancer surgery, followed by ovarian cancer surgery. They also increase a man’s chance of developing male breast cancer and prostate cancer. *The BRCA results are available after 4 weeks.
Combined Female tumour markers
£1,148.85
The combined male tumour markers test measures the tumour (cancer) markers Alpha fetoprotein (AFP), Carcino Embryonic Antigen (CEA), CA 199, CA 125, BRCA1 and BRCA2. There are pros and cons to doing such a test and it is really important that before doing any genetic/cancer monitoring/predicting test, you speak to a clinician to determine if this is the right test for your, and how to manage the results.
Est. Result Turnaround Time : 4 hours to 4 weeks*
Additional information
| Est Result Turnaround Time | 4 hours to 4 weeks* |
|---|
Related products
Polycystic ovary blood test – short POLYCYSTIC OVARY SYNDROME: SHORT
£213.90Antenatal basic
£404.80Erectile dysfunction
£286.35Pre-pregnancy blood test
£414.00
